EXPEDITED REVIEW
Pathology of Drug-Eluting Stents in Humans
Delayed Healing and Late Thrombotic Risk
Michael Joner, MD*,
Aloke V. Finn, MD ,
Andrew Farb, MD ,
Erik K. Mont, MD ,
Frank D. Kolodgie, PhD*,
Elena Ladich, MD*,
Robert Kutys, MS*,
Kristi Skorija, BS*,
Herman K. Gold, MD and
Renu Virmani, MD*,*
* CVPath, International Registry of Pathology, Gaithersburg, Maryland
Cardiac Unit, Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts
Miami Dade County Medical Examiner Department, Heart Radiology, Miami, Florida; and the Interventional Cardiology Devices Branch, U.S. Food and Drug Administration, Rockville, Maryland
Manuscript received January 26, 2006;
revised manuscript received March 10, 2006,
accepted March 16, 2006.
* Reprint requests and correspondence: Dr. Renu Virmani, CVPath, International Registry of Pathology, 19 Firstfield Road, Gaithersburg, Maryland 20878
(Email: rvirmani{at}cvpath.org).
OBJECTIVES: This study examined human drug-eluting stents (DES) to determine the long-term effects of these stents on coronary arterial healing and identified mechanisms underlying late stent thrombosis (LST).
BACKGROUND: Although DES reduce the need for repeat revascularization compared with bare-metal stents (BMS), data suggest the window of thrombotic risk for Cypher (Cordis Corp., Miami Lakes, Florida) and Taxus (Boston Scientific Corp., Natick, Massachusetts) DES extends far beyond that for BMS.
METHODS: From a registry of 40 autopsies of DES (68 stents), 23 DES cases of >30 days duration were compared with 25 matched autopsies of BMS implantation. Late stent thrombosis was defined as an acute thrombus within a stent >30 days old.
RESULTS: Of 23 patients with DES >30 days old, 14 had evidence of LST. Cypher and Taxus DES showed greater delayed healing characterized by persistent fibrin deposition (fibrin score 2.3 ± 1.1 vs. 0.9 ± 0.8, p = 0.0001) and poorer endothelialization (55.8 ± 26.5%) compared with BMS (89.8 ± 20.9, p = 0.0001). Moreover, DES with LST showed more delayed healing compared with patent DES. In 5 of 14 patients suffering LST, antiplatelet therapy had been withdrawn. Additional procedural and pathologic risk factors for LST were: 1) local hypersensitivity reaction; 2) ostial and/or bifurcation stenting; 3) malapposition/incomplete apposition; 4) restenosis; and 5) strut penetration into a necrotic core.
CONCLUSIONS: The Cypher and Taxus DES result in delayed arterial healing when compared with BMS of similar implant duration. The cause of DES LST is multifactorial with delayed healing in combination with other clinical and procedural risk factors playing a role.
|
Abbreviations and Acronyms
| | BMS = bare-metal stents | | DES = drug-eluting stents | | FDA = Food and Drug Administration | | LST = late stent thrombosis |
|
Related Article
-
Drug-Eluting Stent Thrombosis: Increasingly Recognized But Too Frequently Overemphasized
- Antonio Colombo and Simon J. Corbett
J. Am. Coll. Cardiol. 2006 48: 203-205.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
D. P. Faxon
Very Late Stent Thrombosis and Late Target Lesion Revascularization: No End in Sight
Circulation,
January 31, 2012;
125(4):
562 - 564.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Sarno, B. Lagerqvist, O. Frobert, J. Nilsson, G. Olivecrona, E. Omerovic, N. Saleh, D. Venetzanos, and S. James
Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
Eur. Heart J.,
January 9, 2012;
(2012)
ehr479v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. A. Ali, A. Kini, and S. K. Sharma
On OCT and Finding the Uncovered Tracks...
J. Am. Coll. Cardiol. Img.,
January 1, 2012;
5(1):
83 - 86.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. W. Serruys, H. M. Garcia-Garcia, and Y. Onuma
From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?
Eur. Heart J.,
January 1, 2012;
33(1):
16 - 25.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Foin, R. Torii, P. Mortier, M. De Beule, N. Viceconte, P. H. Chan, J. E. Davies, X. Y. Xu, R. Krams, and C. Di Mario
Kissing Balloon or Sequential Dilation of the Side Branch and Main Vessel for Provisional Stenting of Bifurcations: Lessons From Micro-Computed Tomography and Computational Simulations
J. Am. Coll. Cardiol. Intv.,
January 1, 2012;
5(1):
47 - 56.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Armstrong, K. K. Yeo, U. Javed, E. Mahmud, M. Patel, K. A. Shunk, J. S. MacGregor, R. I. Low, and J. H. Rogers
Angiographic Stent Thrombosis at Coronary Bifurcations: Short- and Long-Term Prognosis
J. Am. Coll. Cardiol. Intv.,
January 1, 2012;
5(1):
57 - 63.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. N. Levine, E. R. Bates, J. C. Blankenship, S. R. Bailey, J. A. Bittl, B. Cercek, C. E. Chambers, S. G. Ellis, R. A. Guyton, S. M. Hollenberg, et al.
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
J. Am. Coll. Cardiol.,
December 6, 2011;
58(24):
e44 - e122.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Writing Committee Members, G. N. Levine, E. R. Bates, J. C. Blankenship, S. R. Bailey, J. A. Bittl, B. Cercek, C. E. Chambers, S. G. Ellis, R. A. Guyton, et al.
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Circulation,
December 6, 2011;
124(23):
e574 - e651.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Gomez-Lara, S. Brugaletta, V. Farooq, Y. Onuma, R. Diletti, S. Windecker, L. Thuesen, D. McClean, J. Koolen, R. Whitbourn, et al.
Head-to-Head Comparison of the Neointimal Response Between Metallic and Bioresorbable Everolimus-Eluting Scaffolds Using Optical Coherence Tomography
J. Am. Coll. Cardiol. Intv.,
December 1, 2011;
4(12):
1271 - 1280.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Brugaletta, J. Gomez-Lara, P. W. Serruys, V. Farooq, R. J. van Geuns, L. Thuesen, D. Dudek, J. Koolen, B. Chevalier, D. McClean, et al.
Serial In Vivo Intravascular Ultrasound-Based Echogenicity Changes of Everolimus-Eluting Bioresorbable Vascular Scaffold During the First 12 Months After Implantation: Insights From the ABSORB B Trial
J. Am. Coll. Cardiol. Intv.,
December 1, 2011;
4(12):
1281 - 1289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Palmerini, G. Dangas, R. Mehran, A. Caixeta, P. Genereux, M. P. Fahy, K. Xu, E. Cristea, A. J. Lansky, and G. W. Stone
Predictors and Implications of Stent Thrombosis in Non-ST-Segment Elevation Acute Coronary Syndromes: The ACUITY Trial
Circ Cardiovasc Interv,
December 1, 2011;
4(6):
577 - 584.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.-H. Lim, W.-W. Seo, W. Choe, C.-K. Kang, J. Park, H.-J. Cho, S. Kyeong, J. Hur, H.-M. Yang, H.-J. Cho, et al.
Stent Coated With Antibody Against Vascular Endothelial-Cadherin Captures Endothelial Progenitor Cells, Accelerates Re-Endothelialization, and Reduces Neointimal Formation
Arterioscler Thromb Vasc Biol,
December 1, 2011;
31(12):
2798 - 2805.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Prati, F. Stazi, J. Dutary, A. La Manna, A. Di Giorgio, T. Pawlosky, N. Gonzalo, M. E. Di Salvo, F. Imola, C. Tamburino, et al.
Detection of very early stent healing after primary angioplasty: an optical coherence tomographic observational study of chromium cobaltum and first-generation drug-eluting stents. The DETECTIVE Study
Heart,
November 15, 2011;
97(22):
1841 - 1846.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. P. de Prado, C. Perez-Martinez, C. Cuellas-Ramon, J. M. Gonzalo-Orden, M. Regueiro-Purrinos, B. Martinez, M. J. Garcia-Iglesias, J. M. Ajenjo, J. R. Altonaga, A. Diego-Nieto, et al.
Time Course of Reendothelialization of Stents in a Normal Coronary Swine Model: Characterization and Quantification
Veterinary Pathology,
November 1, 2011;
48(6):
1109 - 1117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Soehnlein, S. Wantha, S. Simsekyilmaz, Y. Doring, R. T. A. Megens, S. F. Mause, M. Drechsler, R. Smeets, S. Weinandy, F. Schreiber, et al.
Neutrophil-Derived Cathelicidin Protects from Neointimal Hyperplasia
Science Translational Medicine,
October 5, 2011;
3(103):
103ra98 - 103ra98.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. L. Dauerman
The Magic of Disappearing Stents
J. Am. Coll. Cardiol.,
October 4, 2011;
58(15):
1589 - 1591.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Gutierrez-Chico, R. J. van Geuns, E. Regar, W. J. van der Giessen, H. Kelbaek, K. Saunamaki, J. Escaned, N. Gonzalo, C. di Mario, F. Borgia, et al.
Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial
Eur. Heart J.,
October 1, 2011;
32(19):
2454 - 2463.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Inoue, K. Croce, T. Morooka, M. Sakuma, K. Node, and D. I. Simon
Vascular Inflammation and Repair: Implications for Re-Endothelialization, Restenosis, and Stent Thrombosis
J. Am. Coll. Cardiol. Intv.,
October 1, 2011;
4(10):
1057 - 1066.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Collet, J. R. Costa, A. Abizaid, D. Chamie, R. Staico, R. Costa, D. Siquera, J. Obregon, F. Feres, A. Sousa, et al.
Assessing the Temporal Course of Neointimal Hyperplasia Formation After Different Generations of Drug-Eluting Stents
J. Am. Coll. Cardiol. Intv.,
October 1, 2011;
4(10):
1067 - 1074.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Kastrati, R. A. Byrne, and S. Schulz
Will We Ever Know the Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation?
J. Am. Coll. Cardiol. Intv.,
October 1, 2011;
4(10):
1129 - 1132.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Dake, G. M. Ansel, M. R. Jaff, T. Ohki, R. R. Saxon, H. B. Smouse, T. Zeller, G. S. Roubin, M. W. Burket, Y. Khatib, et al.
Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease: Twelve-Month Zilver PTX Randomized Study Results
Circ Cardiovasc Interv,
October 1, 2011;
4(5):
495 - 504.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Llano, D. Winsor-Hines, D. B. Patel, P. S. Seifert, D. Hamamdzic, G. J. Wilson, H. Wang, M. G. Keane, B. A. Huibregtse, and R. L. Wilensky
Vascular Responses to Drug-Eluting and Bare Metal Stents in Diabetic/Hypercholesterolemic and Nonatherosclerotic Porcine Coronary Arteries
Circ Cardiovasc Interv,
October 1, 2011;
4(5):
438 - 446.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Gomez-Lara, M. Radu, S. Brugaletta, V. Farooq, R. Diletti, Y. Onuma, S. Windecker, L. Thuesen, D. McClean, J. Koolen, et al.
Serial Analysis of the Malapposed and Uncovered Struts of the New Generation of Everolimus-Eluting Bioresorbable Scaffold With Optical Coherence Tomography
J. Am. Coll. Cardiol. Intv.,
September 1, 2011;
4(9):
992 - 1001.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Gutierrez-Chico, E. Regar, E. Nuesch, T. Okamura, J. Wykrzykowska, C. di Mario, S. Windecker, G.-A. van Es, P. Gobbens, P. Juni, et al.
Delayed Coverage in Malapposed and Side-Branch Struts With Respect to Well-Apposed Struts in Drug-Eluting Stents: In Vivo Assessment With Optical Coherence Tomography
Circulation,
August 2, 2011;
124(5):
612 - 623.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Klomp, M. A. Beijk, C. Varma, J. J. Koolen, E. Teiger, G. Richardt, F. Bea, N. van Geloven, N. J. Verouden, Y. K. Chan, et al.
1-Year Outcome of TRIAS HR (TRI-Stent Adjudication Study-High Risk of Restenosis): A Multicenter, Randomized Trial Comparing Genous Endothelial Progenitor Cell Capturing Stents With Drug-Eluting Stents
J. Am. Coll. Cardiol. Intv.,
August 1, 2011;
4(8):
896 - 904.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-N. Wang, N. Shi, W.-B. Xie, X. Guo, and S.-Y. Chen
Response Gene to Complement 32 Promotes Vascular Lesion Formation Through Stimulation of Smooth Muscle Cell Proliferation and Migration
Arterioscler Thromb Vasc Biol,
August 1, 2011;
31(8):
e19 - e26.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Caglayan, M. Vantler, O. Leppanen, F. Gerhardt, L. Mustafov, H. ten Freyhaus, K. Kappert, M. Odenthal, W. H. Zimmermann, M. D. Tallquist, et al.
Disruption of Platelet-Derived Growth Factor-Dependent Phosphatidylinositol 3-Kinase and Phospholipase C{gamma} 1 Activity Abolishes Vascular Smooth Muscle Cell Proliferation and Migration and Attenuates Neointima Formation In Vivo
J. Am. Coll. Cardiol.,
June 21, 2011;
57(25):
2527 - 2538.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Cutlip
Five-Year Outcomes of Sirolimus-Eluting and Paclitaxel-Eluting Stents in Routine Clinical Practice: Are They Equally Good (or Bad)?
Circulation,
June 21, 2011;
123(24):
2779 - 2781.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-Y. Choi, B. Witzenbichler, A. Maehara, A. J. Lansky, G. Guagliumi, B. Brodie, M. A. Kellett Jr, O. Dressler, H. Parise, R. Mehran, et al.
Intravascular Ultrasound Findings of Early Stent Thrombosis After Primary Percutaneous Intervention in Acute Myocardial Infarction: A Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Substudy
Circ Cardiovasc Interv,
June 1, 2011;
4(3):
239 - 247.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Waseda, J. Ako, M. Yamasaki, T. Koizumi, R. Sakurai, Y. Hongo, B.-K. Koo, J. Ormiston, S. G. Worthley, R. J. Whitbourn, et al.
Impact of Polymer Formulations on Neointimal Proliferation After Zotarolimus-Eluting Stent With Different Polymers: Insights From the RESOLUTE Trial
Circ Cardiovasc Interv,
June 1, 2011;
4(3):
248 - 255.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Imai, K. Kadota, T. Goto, S. Fujii, H. Yamamoto, Y. Fuku, S. Hosogi, A. Hirono, H. Tanaka, T. Tada, et al.
Incidence, Risk Factors, and Clinical Sequelae of Angiographic Peri-Stent Contrast Staining After Sirolimus-Eluting Stent Implantation
Circulation,
May 31, 2011;
123(21):
2382 - 2391.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Tsuburaya, S. Yasuda, T. Shiroto, Y. Ito, J. Y. Gao, K. Aizawa, Y. Kikuchi, K. Ito, J. Takahashi, H. Ishibashi-Ueda, et al.
Long-term treatment with nifedipine suppresses coronary hyperconstricting responses and inflammatory changes induced by paclitaxel-eluting stent in pigs in vivo: possible involvement of Rho-kinase pathway
Eur. Heart J.,
May 30, 2011;
(2011)
ehr145v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Cutlip, G. Nakazawa, M. W. Krucoff, M. Vorpahl, R. Mehran, A. V. Finn, P. Vranckx, C. Kimmelstiel, C. Berger, J. L. Petersen, et al.
Autopsy Validation Study of the Academic Research Consortium Stent Thrombosis Definition
J. Am. Coll. Cardiol. Intv.,
May 1, 2011;
4(5):
554 - 559.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Farooq, B. D. Gogas, and P. W. Serruys
Restenosis: Delineating the Numerous Causes of Drug-Eluting Stent Restenosis
Circ Cardiovasc Interv,
April 1, 2011;
4(2):
195 - 205.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Otake, Y. Honda, B. K. Courtney, T. Shimohama, J. Ako, K. Waseda, N. Macours, C. Rogers, J. J. Popma, A. Abizaid, et al.
Intravascular Ultrasound Results From the NEVO ResElution-I Trial: A Randomized, Blinded Comparison of Sirolimus-Eluting NEVO Stents With Paclitaxel-Eluting Taxus Liberte Stents in De Novo Native Coronary Artery Lesions
Circ Cardiovasc Interv,
April 1, 2011;
4(2):
146 - 154.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Onuma and P. W. Serruys
Bioresorbable Scaffold: The Advent of a New Era in Percutaneous Coronary and Peripheral Revascularization?
Circulation,
February 22, 2011;
123(7):
779 - 797.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Boudriot, H. Thiele, T. Walther, C. Liebetrau, P. Boeckstegers, T. Pohl, B. Reichart, H. Mudra, F. Beier, B. Gansera, et al.
Randomized Comparison of Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis
J. Am. Coll. Cardiol.,
February 1, 2011;
57(5):
538 - 545.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Habara, K. Mitsudo, K. Kadota, T. Goto, S. Fujii, H. Yamamoto, H. Katoh, N. Oka, Y. Fuku, S. Hosogi, et al.
Effectiveness of Paclitaxel-Eluting Balloon Catheter in Patients With Sirolimus-Eluting Stent Restenosis
J. Am. Coll. Cardiol. Intv.,
February 1, 2011;
4(2):
149 - 154.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Nakamura, B. C. Brott, I. Brants, D. Panchal, J. Li, J. P. Chen, S. B. King III, N. Chronos, and D. Hou
Vasomotor Function After Paclitaxel-Coated Balloon Post-Dilation in Porcine Coronary Stent Model
J. Am. Coll. Cardiol. Intv.,
February 1, 2011;
4(2):
247 - 255.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Nakazawa, M. Nakano, F. Otsuka, J. N. Wilcox, R. Melder, S. Pruitt, F. D. Kolodgie, and R. Virmani
Evaluation of Polymer-Based Comparator Drug-Eluting Stents Using a Rabbit Model of Iliac Artery Atherosclerosis
Circ Cardiovasc Interv,
February 1, 2011;
4(1):
38 - 46.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Nakazawa, A. V. Finn, M. Vorpahl, E. R. Ladich, F. D. Kolodgie, and R. Virmani
Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents
J. Am. Coll. Cardiol.,
January 25, 2011;
57(4):
390 - 398.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Guagliumi, M. A. Costa, V. Sirbu, G. Musumeci, H. G. Bezerra, N. Suzuki, A. Matiashvili, N. Lortkipanidze, L. Mihalcsik, A. Trivisonno, et al.
Strut Coverage and Late Malapposition With Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Acute Myocardial Infarction: Optical Coherence Tomography Substudy of the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial
Circulation,
January 25, 2011;
123(3):
274 - 281.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.-H. Chen and R. Matyal
The Management of Antiplatelet Therapy in Patients With Coronary Stents Undergoing Noncardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia,
December 1, 2010;
14(4):
256 - 273.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. A. Ormiston, A. Abizaid, J. Spertus, J. Fajadet, L. Mauri, J. Schofer, S. Verheye, J. Dens, L. Thuesen, C. Dubois, et al.
Six-Month Results of the NEVO RES-ELUTION I (NEVO RES-I) Trial: A Randomized, Multicenter Comparison of the NEVO Sirolimus-Eluting Coronary Stent With the TAXUS Liberte Paclitaxel-Eluting Stent in De Novo Native Coronary Artery Lesions
Circ Cardiovasc Interv,
December 1, 2010;
3(6):
556 - 564.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Onuma, P. W. Serruys, L. E. L. Perkins, T. Okamura, N. Gonzalo, H. M. Garcia-Garcia, E. Regar, M. Kamberi, J. C. Powers, R. Rapoza, et al.
Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: An Attempt to Decipher the Human Optical Coherence Tomography Images in the ABSORB Trial
Circulation,
November 30, 2010;
122(22):
2288 - 2300.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. W. Serruys, Y. Onuma, J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, et al.
Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis: Six-Month Clinical and Imaging Outcomes
Circulation,
November 30, 2010;
122(22):
2301 - 2312.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Niccoli, R. A. Montone, G. Ferrante, and F. Crea
The Evolving Role of Inflammatory Biomarkers in Risk Assessment After Stent Implantation
J. Am. Coll. Cardiol.,
November 23, 2010;
56(22):
1783 - 1793.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. I. Lev, D. Leshem-Lev, A. Mager, H. Vaknin-Assa, N. Harel, Y. Zimra, T. Bental, G. Greenberg, D. Dvir, A. Solodky, et al.
Circulating endothelial progenitor cell levels and function in patients who experienced late coronary stent thrombosis
Eur. Heart J.,
November 1, 2010;
31(21):
2625 - 2632.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.-J. Kim, J.-Y. Kim, S. J. Lee, H.-J. Kim, C. J. Oh, Y.-K. Choi, H.-J. Lee, J.-Y. Do, S.-Y. Kim, T.-K. Kwon, et al.
{alpha}-Lipoic Acid Prevents Neointimal Hyperplasia Via Induction of p38 Mitogen-Activated Protein Kinase/Nur77-Mediated Apoptosis of Vascular Smooth Muscle Cells and Accelerates Postinjury Reendothelialization
Arterioscler Thromb Vasc Biol,
November 1, 2010;
30(11):
2164 - 2172.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. R. Holmes Jr, D. J. Kereiakes, S. Garg, P. W. Serruys, G. J. Dehmer, S. G. Ellis, D. O. Williams, T. Kimura, and D. J. Moliterno
Stent Thrombosis
J. Am. Coll. Cardiol.,
October 19, 2010;
56(17):
1357 - 1365.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Leon, E. Nikolsky, D. E. Cutlip, L. Mauri, H. Liberman, H. Wilson, J. Patterson, J. Moses, D. E. Kandzari, and for the ENDEAVOR IV Investigators
Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions: 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial
J. Am. Coll. Cardiol. Intv.,
October 1, 2010;
3(10):
1043 - 1050.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Tanaka, M. Terashima, S. Rathore, T. Itoh, M. Habara, K. Nasu, M. Kimura, T. Itoh, Y. Kinoshita, M. Ehara, et al.
Different Patterns of Vascular Response Between Patients With or Without Diabetes Mellitus After Drug-Eluting Stent Implantation: Optical Coherence Tomographic Analysis
J. Am. Coll. Cardiol. Intv.,
October 1, 2010;
3(10):
1074 - 1079.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Takano, M. Yamamoto, M. Mizuno, D. Murakami, T. Inami, N. Kimata, K. Murai, N. Kobayashi, K. Okamatsu, T. Ohba, et al.
Late Vascular Responses From 2 to 4 Years After Implantation of Sirolimus-Eluting Stents: Serial Observations by Intracoronary Optical Coherence Tomography
Circ Cardiovasc Interv,
October 1, 2010;
3(5):
476 - 483.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Yamaji, T. Kimura, T. Morimoto, Y. Nakagawa, K. Inoue, Y. Soga, T. Arita, S. Shirai, K. Ando, K. Kondo, et al.
Very Long-Term (15 to 20 Years) Clinical and Angiographic Outcome After Coronary Bare Metal Stent Implantation
Circ Cardiovasc Interv,
October 1, 2010;
3(5):
468 - 475.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Guo, A. Maehara, G. S. Mintz, Y. He, K. Xu, X. Wu, A. J. Lansky, B. Witzenbichler, G. Guagliumi, B. Brodie, et al.
Incidence, Mechanisms, Predictors, and Clinical Impact of Acute and Late Stent Malapposition After Primary Intervention in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Substudy of the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial
Circulation,
September 14, 2010;
122(11):
1077 - 1084.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Garg and P. W. Serruys
Coronary Stents: Current Status
J. Am. Coll. Cardiol.,
August 31, 2010;
56(10_Suppl_S):
S1 - S42.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Garg and P. W. Serruys
Coronary Stents: Looking Forward
J. Am. Coll. Cardiol.,
August 31, 2010;
56(10_Suppl_S):
S43 - S78.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. Schwartz, D. R. Holmes, R. A. Van Tassel, R. Hauser, T. D. Henry, M. Mooney, R. Matthews, S. Doshi, R. M. Jones, and R. Virmani
Left Atrial Appendage Obliteration: Mechanisms of Healing and Intracardiac Integration
J. Am. Coll. Cardiol. Intv.,
August 1, 2010;
3(8):
870 - 877.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Kimura, T. Morimoto, K. Kozuma, Y. Honda, T. Kume, T. Aizawa, K. Mitsudo, S. Miyazaki, T. Yamaguchi, E. Hiyoshi, et al.
Comparisons of Baseline Demographics, Clinical Presentation, and Long-Term Outcome Among Patients With Early, Late, and Very Late Stent Thrombosis of Sirolimus-Eluting Stents: Observations From the Registry of Stent Thrombosis for Review and Reevaluation (RESTART)
Circulation,
July 6, 2010;
122(1):
52 - 61.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Templin, M. Meyer, M. F. Muller, V. Djonov, R. Hlushchuk, I. Dimova, S. Flueckiger, P. Kronen, M. Sidler, K. Klein, et al.
Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy
Eur. Heart J.,
July 2, 2010;
31(14):
1792 - 1801.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Gaglia Jr, R. Torguson, Z. Xue, M. A. Gonzalez, S. D. Collins, I. Ben-Dor, A. I. Syed, G. Maluenda, C. Delhaye, N. Hanna, et al.
Insurance Type Influences the Use of Drug-Eluting Stents
J. Am. Coll. Cardiol. Intv.,
July 1, 2010;
3(7):
773 - 779.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Balcells, J. Martorell, C. Olive, M. Santacana, V. Chitalia, A. A. Cardoso, and E. R. Edelman
Smooth Muscle Cells Orchestrate the Endothelial Cell Response to Flow and Injury
Circulation,
May 25, 2010;
121(20):
2192 - 2199.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. W. Lee, S. J. Kang, D. W. Park, S. H. Lee, Y. H. Kim, J. J. Kim, S. W. Park, G. S. Mintz, and S. J. Park
Intravascular Ultrasound Findings in Patients With Very Late Stent Thrombosis After Either Drug-Eluting or Bare-Metal Stent Implantation
J. Am. Coll. Cardiol.,
May 4, 2010;
55(18):
1936 - 1942.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. M. Hassan, S. C. Bergheanu, T. Stijnen, B. L. van der Hoeven, J. D. Snoep, J. W. M. Plevier, M. J. Schalij, and J. Wouter Jukema
Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis
Eur. Heart J.,
May 2, 2010;
31(10):
1172 - 1180.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. M. Beijk, M. Klomp, N. J. W. Verouden, N. van Geloven, K. T. Koch, J. P. S. Henriques, J. Baan, M. M. Vis, E. Scheunhage, J. J. Piek, et al.
GenousTM endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study
Eur. Heart J.,
May 1, 2010;
31(9):
1055 - 1064.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Garg, H. J. Duckers, and P. W. Serruys
Endothelial progenitor cell capture stents: will this technology find its niche in contemporary practice?
Eur. Heart J.,
May 1, 2010;
31(9):
1032 - 1035.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Guagliumi, G. Musumeci, V. Sirbu, H. G. Bezerra, N. Suzuki, L. Fiocca, A. Matiashvili, N. Lortkipanidze, A. Trivisonno, O. Valsecchi, et al.
Optical Coherence Tomography Assessment of In Vivo Vascular Response After Implantation of Overlapping Bare-Metal and Drug-Eluting Stents
J. Am. Coll. Cardiol. Intv.,
May 1, 2010;
3(5):
531 - 539.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Ma, B. Hibbert, B. Dhaliwal, T. Seibert, Y. X. Chen, X. Zhao, and E. R. O'Brien
Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3{beta} inhibitor
Cardiovasc Res,
May 1, 2010;
86(2):
338 - 345.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Nakazawa, S. K. Yazdani, A. V. Finn, M. Vorpahl, F. D. Kolodgie, and R. Virmani
Pathological Findings at Bifurcation Lesions: The Impact of Flow Distribution on Atherosclerosis and Arterial Healing After Stent Implantation
J. Am. Coll. Cardiol.,
April 20, 2010;
55(16):
1679 - 1687.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Tada, R. Virmani, G. Grant, L. Bartlett, A. Black, C. Clavijo, U. Christians, R. Betts, D. Savage, S. H. Su, et al.
Polymer-Free Biolimus A9-Coated Stent Demonstrates More Sustained Intimal Inhibition, Improved Healing, and Reduced Inflammation Compared With a Polymer-Coated Sirolimus-Eluting Cypher Stent in a Porcine Model
Circ Cardiovasc Interv,
April 1, 2010;
3(2):
174 - 183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Garg and P. W Serruys
Drug-eluting stents: a reappraisal
Heart,
April 1, 2010;
96(7):
489 - 493.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Grube, J. Schofer, K. E. Hauptmann, G. Nickenig, N. Curzen, D. J. Allocco, and K. D. Dawkins
A Novel Paclitaxel-Eluting Stent With an Ultrathin Abluminal Biodegradable Polymer: 9-Month Outcomes With the JACTAX HD Stent
J. Am. Coll. Cardiol. Intv.,
April 1, 2010;
3(4):
431 - 438.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Virmani, G. J. Wilson, and A. V. Finn
Letter by Virmani et al Regarding Article, "Drug-Eluting Stents in Animals and Patients: Where Do We Stand Today?"
Circulation,
March 23, 2010;
121(11):
e246 - e246.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Violini, C. Musto, F. De Felice, M. S. Nazzaro, A. Cifarelli, T. Petitti, and R. Fiorilli
Maintenance of Long-Term Clinical Benefit With Sirolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 3-Year Results of the SESAMI (Sirolimus-Eluting Stent Versus Bare-Metal Stent In Acute Myocardial Infarction) Trial
J. Am. Coll. Cardiol.,
February 23, 2010;
55(8):
810 - 814.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Leon, L. Mauri, J. J. Popma, D. E. Cutlip, E. Nikolsky, C. O'Shaughnessy, P. A. Overlie, B. T. McLaurin, S. L. Solomon, J. S. Douglas Jr, et al.
A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions: 12-Month Outcomes From the ENDEAVOR IV Trial
J. Am. Coll. Cardiol.,
February 9, 2010;
55(6):
543 - 554.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. O. Abualsaud and M. J. Eisenberg
Perioperative Management of Patients With Drug-Eluting Stents
J. Am. Coll. Cardiol. Intv.,
February 1, 2010;
3(2):
131 - 142.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Undas, J. Zalewski, M. Krochin, Z. Siudak, M. Sadowski, J. Pregowski, D. Dudek, M. Janion, A. Witkowski, and K. Zmudka
Altered Plasma Fibrin Clot Properties Are Associated With In-Stent Thrombosis
Arterioscler Thromb Vasc Biol,
February 1, 2010;
30(2):
276 - 282.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Barlis, E. Regar, P. W. Serruys, K. Dimopoulos, W. J. van der Giessen, R.-J. M. van Geuns, G. Ferrante, S. Wandel, S. Windecker, G.-A. van Es, et al.
An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study
Eur. Heart J.,
January 2, 2010;
31(2):
165 - 176.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Leigh Perkins
Preclinical Models of Restenosis and Their Application in the Evaluation of Drug-Eluting Stent Systems
Veterinary Pathology,
January 1, 2010;
47(1):
58 - 76.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Windecker and L. Raber
The DESIRE-Late Registry: What Is Left to Be Desired?
J. Am. Coll. Cardiol. Intv.,
January 1, 2010;
3(1):
19 - 21.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Nakazawa, J. F. Granada, C. L. Alviar, A. Tellez, G. L. Kaluza, M. Y. Guilhermier, S. Parker, S. M. Rowland, F. D. Kolodgie, M. B. Leon, et al.
Anti-CD34 Antibodies Immobilized on the Surface of Sirolimus-Eluting Stents Enhance Stent Endothelialization
J. Am. Coll. Cardiol. Intv.,
January 1, 2010;
3(1):
68 - 75.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. M.M. van Beusekom and P. W. Serruys
Drug-Eluting Stent Endothelium: Presence or Dysfunction
J. Am. Coll. Cardiol. Intv.,
January 1, 2010;
3(1):
76 - 77.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Vasa-Nicotera and T. Gershlick
Chapter 29 Stent thrombosis
Oxford Textbook of Interventional Cardiology,
January 1, 2010;
1(1):
med-9780199569083-chapter - med-9780199569083-chapter.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. E. Kandzari, A. Farb, and A. B. Boam
Percutaneous Coronary Intervention in Perspective: Drug-Eluting Stents as a Model for Regulatory Review
Circ Cardiovasc Interv,
December 1, 2009;
2(6):
574 - 579.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. K. Pendyala, X. Yin, J. Li, J. P. Chen, N. Chronos, and D. Hou
The First-Generation Drug-Eluting Stents and Coronary Endothelial Dysfunction
J. Am. Coll. Cardiol. Intv.,
December 1, 2009;
2(12):
1169 - 1177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Leon, D. E. Kandzari, E. L. Eisenstein, K. J. Anstrom, L. Mauri, D. E. Cutlip, E. Nikolsky, C. O'Shaughnessy, P. A. Overlie, A. J. Kirtane, et al.
Late Safety, Efficacy, and Cost-Effectiveness of a Zotarolimus-Eluting Stent Compared With a Paclitaxel-Eluting Stent in Patients With De Novo Coronary Lesions: 2-Year Follow-Up From the ENDEAVOR IV Trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)
J. Am. Coll. Cardiol. Intv.,
December 1, 2009;
2(12):
1208 - 1218.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
American College of Cardiology Foundation, American Heart Association Task Force on Practice, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interve, Society for Vascular Medicine, Society for Vascular Surgery, L. A. Fleisher, et al.
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
J. Am. Coll. Cardiol.,
November 24, 2009;
54(22):
e13 - e118.
[Full Text]
[PDF]
|
|
|
|
|
|
|
2007 WRITING COMMITTEE MEMBERS, L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. L. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, et al.
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation,
November 24, 2009;
120(21):
e169 - e276.
[Full Text]
[PDF]
|
|
|
|
